|
|
R. Gisli Jenkins, Xiao Su, George Su, Christopher J. Scotton, Eric Camerer, Geoffrey J. Laurent, George E. Davis, Rachel C. Chambers, Michael A. Matthay, Dean Sheppard
J Clin Invest. 2006;
116(6):1606
doi:10.1172/JCI27183
Abstract |
Full text
| PDF

A
ctivation of latent TGF-β by the αvβ6 integrin is a critical step in the development of acute lung injury. However, the mechanism by which αvβ6-mediated TGF-β activation is regulated has not been identified. We show that thrombin, and other agonists of protease-activated receptor 1 (PAR1), activate TGF-β in an αvβ6 integrin–specific manner. This effect is PAR1 specific and is mediated by RhoA and Rho kinase. Intratracheal instillation of the PAR1-specific peptide TFLLRN increases lung edema during high-tidal-volume ventilation, and this effect is completely inhibited by a blocking antibody against the αvβ6 integrin. Instillation of TFLLRN during high-tidal-volume ventilation is associated with increased pulmonary TGF-β activation; however, this is not observed in Itgb6–/– mice. Furthermore, Itgb6–/– mice are also protected from ventilator-induced lung edema. We also demonstrate that pulmonary edema and TGF-β activity are similarly reduced in Par1–/– mice following bleomycin-induced lung injury. These results suggest that PAR1-mediated enhancement of αvβ6-dependent TGF-β activation could be one mechanism by which activation of the coagulation cascade contributes to the development of acute lung injury, and they identify PAR1 and the αvβ6 integrin as potential therapeutic targets in this condition.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
About CrossRef
| Title and authors |
Publication |
Year |
. |
Myofibroblast differentiation and survival in fibrotic disease
Kornelia Kis, Xiaoqiu Liu, James S. Hagood |
Exp Rev Mol Med |
2011 |
.
|
Integrin–TGF-β crosstalk in fibrosis, cancer and wound healing
Coert Margadant, Arnoud Sonnenberg |
EMBO Rep |
2010 |
.
|
The myofibroblast: Paradigm for a mechanically active cell
Boris Hinz |
J Biom |
2010 |
.
|
The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice
Kristy A. Bauman, Scott H. Wettlaufer, Katsuhide Okunishi, Kevin M. Vannella, Joshua S. Stoolman, Steven K. Huang, Anthony J. Courey, Eric S. White, Cory M. Hogaboam, Richard H. Simon, Galen B. Toews, Thomas H. Sisson, Bethany B. Moore, Marc Peters-Golden |
Journal Clinical Investigation |
2010 |
.
|
Critical Role of the Small GTPase RhoA in the Development of Pulmonary Edema Induced by Pseudomonas aeruginosa in Mice
Michel Carles, Mathieu Lafargue, Arnaud Goolaerts, Jérémie Roux, Yuanlin Song, Marybeth Howard, David Weston, John T. Swindle, Joe Hedgpeth, Fanny Burel-Vandenbos, Jean-Francois Pittet |
Anesthesiology |
2010 |
.
|
B. HINZ |
Regenerative medicine and biomaterials for the repair of connective tissues |
2010 |
.
|
Mechanisms of the epithelial–mesenchymal transition by TGF-β
Michael K Wendt, Tressa M Allington, William P Schiemann |
Future Oncol |
2009 |
.
|
Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury
Chris J. Scotton, Malvina A. Krupiczojc, Melanie Königshoff, Paul F. Mercer, Y.C. Gary Lee, Naftali Kaminski, John Morser, Joseph M. Post, Toby M. Maher, Andrew G. Nicholson, James D. Moffatt, Geoffrey J. Laurent, Claudia K. Derian, Oliver Eickelberg, Rachel C. Chambers |
Journal Clinical Investigation |
2009 |
.
|
Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention?
R C Chambers |
British Journal of Pharmacology |
2009 |
.
|
The coagulation system and pulmonary endothelial function in acute lung injury
James H. Finigan |
Microvas Res |
2009 |
.
|
Tissue stiffness, latent TGF-β1 Activation, and mechanical signal transduction: Implications for the pathogenesis and treatment of fibrosis
Boris Hinz |
Curr Rheumatol Rep |
2009 |
.
|
Bioactive TGF-β levels can be preserved in plasma samples collected into heparin but not EDTA
Michael Walther, Isatou K. Jallow, David Jeffries, Brigitte Walther |
Cyto |
2009 |
.
|
Perturbation of transforming growth factor (TGF)-ss1 association with latent TGF- binding protein yields inflammation and tumors
K. Yoshinaga, H. Obata, V. Jurukovski, R. Mazzieri, Y. Chen, L. Zilberberg, D. Huso, J. Melamed, P. Prijatelj, V. Todorovic, B. Dabovic, D. B. Rifkin |
Proc Natl Acad Sci U S A |
2008 |
.
|
Treating lung infections with anticoagulation: Mechanisms matter*
Jean Francois Pittet, Yuanlin Song, Jeanine P. Wiener-Kronish |
Crit Care Med |
2008 |
.
|
Transforming Growth Factor-βActivation in the Lung: Focus on Fibrosis and Reactive Oxygen Species
Katri Koli, Marjukka Myllärniemi, Jorma Keski-Oja, Vuokko L. Kinnula |
Antioxidants & Redox Signaling |
2008 |
.
|
Downregulation of protease-activated receptor-1 in human lung fibroblasts is specifically mediated by the prostaglandin E2receptor EP2 through cAMP elevation and protein kinase A
Elena Sokolova, Roland Hartig, Georg Reiser |
FEBS J |
2008 |
.
|
Myofibroblast contraction activates latent TGF- 1 from the extracellular matrix
P.-J. Wipff, D. B. Rifkin, J.-J. Meister, B. Hinz |
J Cell Biol |
2007 |
.
|
|
|
|